Top Markets
#1 Cortex Cortex +173.72%
#2 Helium Helium +60.27%
#3 GEKKO GEKKO +50.71%
#4 Pons Pons +20.78%
#5 ADO Protocol ADO Protocol +17.96%
#6 o1.exchange o1.exchange +13.64%
#7 Collect on Fanable Collect on Fanable +12.30%
#8 Status Status +11.10%
#9 龙虾 (Lobster) 龙虾 (Lobster) +10.81%
#10 Siren Siren +10.57%
Coin of the day
Cortex Cortex
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Inventiva S.A. Inventiva S.A.

Inventiva S.A.

IVA
Classificação em ações #8990
Inventiva S.A. is a biopharmaceutical firm currently in the clinical... Inventiva S.A. is a biopharmaceutical firm currently in the clinical development phase, specializing in creating orally administered small molecule treatments for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other ailments. Their primary drug candidate, Lanifibranor, has successfully concluded Phase IIb clinical trials for the management of NASH. Furthermore, the company is advancing Odiparcil, a compound that has finished Phase IIa clinical testing specifically for treating the MPS VI subtype. Beyond these, Inventiva maintains a development pipeline featuring several early-stage projects targeting oncology and other medical conditions. Strategic partnerships are in place with AbbVie to address autoimmune diseases, and with Boehringer Ingelheim International GmbH for innovating therapies for idiopathic pulmonary fibrosis. Established in 2011, Inventiva S.A. operates from its headquarters in Daix, France.
Preço da ação
$4.74
Última sincronização: 2026-08-28
Valor de mercado
$1.12B
Variação (1 dia)
-5.77%
Variação (1 ano)
-16.96%
País
FR
Negociar Inventiva S.A. (IVA)

Categoria

Healthcare
Histórico de preços das ações de Inventiva S.A. (IVA)
Preço de fecho mais alto: $4.81 em 2026-08-01

Preço de fecho mais baixo: $8.81 em 2017-02-01
Histórico de preços das ações da Inventiva S.A. de 2017 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 16.21%
2025 81.56%
2024 -45.71%
2023 -2.51%
2022 -66.57%
2021 5.74%
2020 247.99%
2019 -44.55%
2018 -2.05%
2017 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $542.09 38.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.03K 44.13%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.70%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.18 473.58%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $759.27 7.20%
CH